Nykode Therapeutics ASA VACBF
$0.35
Last Updated: Aug 11, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
VACBF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Nykode Therapeutics ASA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Nykode Therapeutics ASA. Stock Analysis VACBF
United States Health Care Micro Cap Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company employs 59 full-time employees The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.
Nykode Therapeutics ASA (VACBF) Chart
Financial Metrics & Statements of Nykode Therapeutics ASA (VACBF)
FAQ's for Nykode Therapeutics ASA (VACBF)
- As of August 2026, Nykode Therapeutics ASA VACBF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nykode Therapeutics ASA using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nykode Therapeutics ASA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nykode Therapeutics ASA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nykode Therapeutics ASA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nykode Therapeutics ASA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nykode Therapeutics ASA (VACBF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
